SCHEMBL23198540

SCHEMBL23198540

CCOC(=O)c1cc(Cl)c2c(n1)CCN(C(=O)OC(C)(C)C)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.48
ESR2 Q92731 1/20 0.42
MTOR P42345 2/20 0.41
MAPT P10636 2/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NR1H2 P55055 1/20 0.39
F12 P00748 1/20 0.39
HSP90AA1 P07900 1/20 0.39
PDE10A Q9Y233 1/20 0.39
C5AR1 P21730 2/20 0.38
PARP1 P09874 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17551377 0.92 ADORA1 (0.50) ADORA1ESR2MTORMAPTTP53
SCHEMBL23198536 0.89 ADORA1 (0.49) ADORA1ESR2MTORMAPTTP53
SCHEMBL23198443 0.83 ADORA1 (0.52) ADORA1ESR2MTORMAPTTP53
SCHEMBL23199090 0.82 ADORA1 (0.51) ADORA1ESR2MTORMAPTTP53
SCHEMBL23200226 0.81 ADORA1 (0.53) ADORA1ESR2MTORMAPTALDH1A1
SCHEMBL24758537 0.81 ADORA1 (0.50) ADORA1ESR2MTORMAPTTP53
SCHEMBL24722778 0.80 ADORA1 (0.48) ADORA1ESR2MTORMAPTTP53
SCHEMBL24759062 0.80 ADORA1 (0.48) ADORA1ESR2MTORMAPTMEN1
SCHEMBL19470792 0.78 NR1H2 (0.37) ADORA1TP53POLBLMNASMN1; SMN2
SCHEMBL17551254 0.78 NR1H2 (0.37) ADORA1TP53POLBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402917-A1 COMPOUND AS SMALL MOLECULE INHIBITOR PD-1/PD-L1 AND APPLICATION THEREOF MEDSHINE DISCOVERY INC. (CN) 2022-12-22 US disclosed
EP-4043461-A1 COMPOUND AS SMALL MOLECULE INHIBITOR PD-1/PD-L1 AND APPLICATION THEREOF Medshine Discovery Inc. (CN) 2022-08-17 EP disclosed
WO-2021063404-A1 COMPOUND AS SMALL MOLECULE INHIBITOR PD-1/PD-L1 AND APPLICATION THEREOF 南京明德新药研发有限公司 2021-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402917-A1 COMPOUND AS SMALL MOLECULE INHIBITOR PD-1/PD-L1 AND APPLICATION THEREOF CD274, PDCD1, PDCD1LG2 ADORA1 2762/4885ESR2 2871/4885MTOR 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.